India is not likely to face any delay in covid-19 vaccines due to its large manufacturing capacity, but there may be a worry that other low- and middle-income countries (LMIC) may face trouble in getting enough vaccine shipments to inoculate their population, said Gagandeep Kang, professor at Christian Medical College and board member of Coalition for Epidemic Preparedness Innovations (CEPI).“I'm worried about the other 91 countries (LMIC) that are in the COVAX facility that have been promised doses for 20% of their populations.
What about the remaining 80%? Where is the funding for those countries to be able to buy the vaccine going to come from? Only when we have a clear path to how that is going to be done, can we really think that we.